Free Trial

Immunic (IMUX) News Today

Immunic logo
$14.17 +1.20 (+9.25%)
As of 11:56 AM Eastern
This is a fair market value price provided by Massive. Learn more.

IMUX Latest News

Immunic (IMUX) Gets a Buy from LifeSci Capital
Immunic Q2 EPS Estimate Boosted by Brookline Capital Markets
Immunic: Saved By A 200 Million Private Placement
Immunic Shareholders Approve Reverse Stock Split Initiative
Immunic to implement 1-for-10 reverse stock split
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
D Boral Capital downgrades Immunic (IMUX)
Immunic Sets 1-for-10 Reverse Stock Split Plan
Immunic stock jumps after Guggenheim initiates with Buy
Immunic to present at healthcare investor conferences in March
Immunic secures $400M to support late-stage MS trials - ICYMI
Immunic sets stage for phase 3 MS data readout after $400M financing
Get Immunic News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMUX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMUX Media Mentions By Week

IMUX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMUX
News Sentiment

-0.66

0.47

Average
Medical
News Sentiment

IMUX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMUX Articles
This Week

2

4

IMUX Articles
Average Week

Get the Latest News and Ratings for IMUX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Immunic and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:IMUX) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners